{
  "count": 1,
  "data": [
    {
      "id": "isomorphic",
      "name": "Isomorphic Labs",
      "short": "Isomorphic",
      "category": "biotech",
      "founded": 2021,
      "employees": "200+",
      "funding": "$600M",
      "funding_num_m": 600,
      "valuation": "Alphabet sub.",
      "focus": "AI drug discovery",
      "ethos": "Solve all disease",
      "hq": "King's Cross",
      "key_people": "Hassabis (CEO), Jaderberg (CTO)",
      "milestones": "$600M A '25 · Lilly/Novartis $3B",
      "founders": "Demis Hassabis",
      "careers_url": "https://www.isomorphiclabs.com/careers",
      "created_at": "2026-03-09T14:51:05.676723+00:00",
      "updated_at": "2026-03-09T14:51:05.676723+00:00",
      "ch_number": "13223825",
      "github_org": null,
      "website_url": "https://isomorphiclabs.com",
      "twitter": null,
      "linkedin_url": "https://linkedin.com/company/isomorphic-labs",
      "logo_url": "https://logo.clearbit.com/isomorphiclabs.com",
      "tags": [
        "biotech",
        "drug-discovery",
        "frontier"
      ],
      "description": "Isomorphic Labs. AI drug discovery. Solve all disease. HQ: King's Cross. Founded: 2021. Funding: $600M. Tags: biotech, drug-discovery, frontier",
      "clients": "Pharma R&D (internal Alphabet + partnerships)"
    }
  ]
}